Advarra

AUGUST 16, 2022

The law established the Office of Orphan Products Development , providing financial incentives for pharmaceutical companies to develop orphan drugs and making it more viable to invest in orphan drug research and development. The impact was clear: Between 1983 and 2020, FDA approved 599 orphan drugs.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

Drug Discovery World

NOVEMBER 16, 2022

It’s hoped that through this, scientists will be able to better predict how drug molecules perform in the body, leading to expedited drug development and better outcomes for patients. . Molecular Devices launched its OIC with the goal of advancing scientific research into 3D biology. Current research .

Pharma Companies 243

Pharma Companies Science Research Drugs 243

NIH Director's Blog: Drug Development

FEBRUARY 16, 2021

This improvement stems from several factors, including the FDA’s emergency use authorization (EUA) of a number of therapies found to be safe and effective for COVID-19. ACTIV was founded last April to accelerate drug research that typically requires more than a decade of clinical ups and downs to develop a safe, effective therapy.

Clinical Trials 52

Clinical Trials Hospitals Vaccine Trials 52

Drug Discovery World

FEBRUARY 9, 2023

The first is that in-roads made in decoding the complexity of human disease will make drug discovery more difficult and costly, limiting the potential to develop new life-saving therapies. I believe this is where the future of drug research and development hinges.

Drugs 130

Drugs Pharmaceuticals Disease Treatment 130

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Bioinformatics 130

Bioinformatics RNA Vaccine Clinical Trials 130

Agency IQ

JUNE 9, 2023

The problems: Although the current regulation stimulated orphan drug research, it didn’t do enough The regulation fostered development of medicines for rare diseases since implementation, but not enough. High-priced cell and gene therapies are being increasingly developed for rare diseases.

Marketing 40

Marketing Biosimilars Regulations Drugs 40

Drug Discovery World

JULY 3, 2024

The AI revolution Artificial intelligence (AI) is becoming an integral tool in drug discovery, and Swiss researchers have been some of the first to capitalise on and progress this new resource. Swiss companies are also applying AI beyond preclinical drug discovery, to clinical trials and upskilling staff.

Drugs 130

Drugs Clinical Trials Science Therapies 130

Codon

JUNE 2, 2024

Without mouse models, we may never have developed polio and meningitis vaccines, organ transplants, GLP-1 drugs, gene therapies , or any other number of transformative treatments. Today, somewhere on the order of 30 million rodents are used yearly in biomedical research in the U.S.

Laboratories 123

Laboratories Research Disease Science 123